AU2005283422C1 — Medicinal composition
Assigned to Eisai R&D Management Co Ltd · Expires 2017-02-02 · 9y expired
What this patent protects
A medicinal composition which comprises: a medicinal ingredient comprising, e.g., 4-(3-chloro-4-(cyclopropylamino-carbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide, a salt thereof, or a solvate of either; and (i) a compound whose 5% (w/w) aqueous solution or dispersion has …
USPTO Abstract
A medicinal composition which comprises: a medicinal ingredient comprising, e.g., 4-(3-chloro-4-(cyclopropylamino-carbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide, a salt thereof, or a solvate of either; and (i) a compound whose 5% (w/w) aqueous solution or dispersion has a pH of 8 or higher and/or (ii) silicic acid, a salt thereof, or a solvate of either. It is a highly stable medicinal composition in which the decomposition of that compound under high-humidity high-temperature storage conditions or surface gelation of the medicinal composition has been reduced to a sufficient level.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.